Home›Companies›Biotech & Pharma›Gibson Oncology

Gibson Oncology, LLC

Updated Oct 29, 2026·Latest SEC filing Jul 21, 2025·Suggest an edit

About Gibson Oncology

Gibson Oncology is a private company based in Miami, Florida. It has reported $4,050,000 raised in two offerings on Form D since October 2024. Its chief executive is Randall Riggs.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 7, 2025Jul 21, 2025$250,000of $1.5M target1$250KEquityRule 506(b)Form D ↗
Apr 23, 2020Oct 31, 2024$3,800,000of $4.7M target8$475KEquityRule 506(b)Form D ↗
Total, two offerings$4,050,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Gibson Oncology's Form D filed Jul 21, 2025.

MC
Mark Cushman
Director
CS
Clifford Solomon
Executive officer and director
ER
Elizabeth Rogers
Executive officer and director
MR
Mark Rogers
Director
TS
Theodore Solomon
Executive officer and director
RR
Randall Riggs
Chief Executive Officer and director
MB
Mark Baganz
Director

Sources

  1. SECGibson Oncology, LLC filing history